HTS-Oracle: Experimentally validated AI-enabled prioritization for generalizable small molecule hit discovery
Nada, H.; Calvo-Barreiro, L.; Fuchs, N.; Kaur, B.; Cho, S.; Upadhyay, S.; Meanwell, N.; Gabr, M.
Show abstract
High-throughput screening (HTS) remains a central pillar of small molecule discovery yet routinely fails for immune receptors and protein-protein interaction-driven targets. Here, we introduce HTS-Oracle, an experimentally validated AI system for prospective hit discovery that integrates molecular language modeling with cheminformatics to prioritize bioactive compounds at scale. We deploy HTS-Oracle across three clinically validated yet historically intractable immune targets, TREM2, CHI3L1, and CD28, representing cryptic binding pockets, intrinsically disordered proteins, and protein-protein interaction-driven immune checkpoint, respectively. Across the tested targets, HTS-Oracle reduces experimental screening requirements by up to >99% while increasing hit rates by up to 176-fold relative to traditional HTS. Notably, the platform remains predictive under extreme data sparsity, achieving an eightfold improvement for CD28 despite fewer than 2% actives in training. By consistently enriching for experimentally validated hits, HTS-Oracle establishes a new performance benchmark for hit discovery and unlocks small molecule access to immune targets long regarded as chemically inaccessible.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identification of activators of human fumarate hydratase by quantitative high-throughput screening 95%
- TREM2 Hit Discovery Using TRIC Technology: A Proof-of-Concept High-Throughput Screening Approach 94%
- Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum, using a nano luciferase reporter read-out 94%
Similar papers in this journal
Similar papers in this journal
- A resource to enable chemical biology and drug discovery of WDR Proteins 96%
- Discovery of CD28-Targeted Small Molecule Inhibitors of T Cell Co-stimulation Using Affinity Selection-Mass Spectrometry (AS-MS) and Ex Vivo Validation 96%
- Illuminating Dark Chemical Matter using the Cell Painting Assay 96%
Similar papers in this journal
- EVOSYNTH: Enabling Multi-Target Drug Discovery through Latent Evolutionary Optimization and Synthesis-Aware Prioritization 94%
- Targeted degradation of GSPT1 and NEK7 by a molecular glue prodrug for treatment of HCC 94%
- Using macromolecular electron densities to improve the enrichment of active compounds in virtual screening 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.